primovist 0.25mmol/ml solution for injection, pre-filled syringe
bayer hellas s.a 6-8 agisilaou street 151 23 marousi attiki, , greece - gadoxetic acid, disodium - solution for injection in a pre-filled syringe - gadoxetic acid, disodium 0.25 mmol/ml - contrast media
primovist solution for injection in vial 0.25 mmolml
bayer (south east asia) pte ltd - gadoxetate, disodium - injection, solution - gadoxetate, disodium 0.25mmol/ml
primovist. 0.25 mmol/ml inj. sol. i.v. pre-filled syr.
bayer sa-nv - disodium gadoxetate 181,43 mg/ml - solution for injection - gadoxetic acid
primovist. 0.25 mmol/ml inj. sol. i.v. pre-filled syr.
bayer sa-nv - disodium gadoxetate 181,43 mg/ml - solution for injection - gadoxetic acid
primovist 0.25 mmol/ml, solution for injection, pre-filled syringe
bayer limited - gadoxetic acid, disodium - solution for injection in pre-filled syringe - 0.25 millimole(s)/millilitre - paramagnetic contrast media; gadoxetic acid
primovist
bayer new zealand limited - gadoxetate disodium 181.43 mg/ml (manufactured in-situ from gadolinium oxide and ethoxybenzyl dtpa) - solution for injection - 181.43 mg/ml - active: gadoxetate disodium 181.43 mg/ml (manufactured in-situ from gadolinium oxide and ethoxybenzyl dtpa) excipient: hydrochloric acid as 3.6% w/w aqueous solution caloxetate complexing agent sodium hydroxide trometamol water for injection - for use in adults for the enhancement of magnetic resonance imaging (mri) of focal liver lesions
primovist 0.25 mmol/ml, solution for injection
bayer limited - gadoxetic acid, disodium - solution for injection - 0.25 millimole(s)/millilitre - paramagnetic contrast media; gadoxetic acid